Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C M Cooper

Showing results (71-80 of 81) with videos related to

Pageof 9
Sort By:
Environmental Pollution (Barking, Essex : 1987)|August 7, 2009
Nutrient mitigation capacity in Mississippi Delta, USA drainage ditchesM T Moore, R Kröger, M A Locke, et al.
The Journal of Biological Chemistry|November 7, 1998
Selective inhibition of factor Xa in the prothrombinase complex by the carboxyl-terminal domain of antistasinS S Mao, C T Przysiecki, J A Krueger, et al.
Clinical Chemistry|June 1, 1989
Multicenter evaluation of TDx test for assessing fetal lung maturityJ C Russell, C M Cooper, C H Ketchum, et al.
Physical Review Letters|July 12, 2017
Spatiotemporal Evolution of Runaway Electron Momentum Distributions in TokamaksC Paz-Soldan, C M Cooper, P Aleynikov, et al.
Internal Medicine Journal|December 9, 2014
Consensus guidelines for optimising antifungal drug delivery and monitoring to avoid toxicity and improve outcomes in patients with haematological malignancy, 2014M M Chau, D C M Kong, S J van Hal, et al.
Physical Review Letters|April 24, 2019
Sustained Neutron Production from a Sheared-Flow Stabilized Z PinchY Zhang, U Shumlak, B A Nelson, et al.
Journal of Medicinal Chemistry|November 14, 1997
Synthesis of a series of potent and orally bioavailable thrombin inhibitors that utilize 3,3-disubstituted propionic acid derivatives in the P3 positionT J Tucker, W C Lumma, S D Lewis, et al.
Bioorganic & Medicinal Chemistry Letters|January 5, 1999
C6 modification of the pyridinone core of thrombin inhibitor L-374,087 as a means of enhancing its oral absorptionR C Isaacs, K J Cutrona, C L Newton, et al.
Epilepsy & Behavior : E&B|July 31, 2025
Depressive symptoms in youth with refractory epilepsy: Exploration of seizure, sociodemographic and cognitive factorsS B Brothers, C Wolfe-Christensen, H J Loblein, et al.
Journal of Medicinal Chemistry|August 14, 1998
Design and synthesis of a series of potent and orally bioavailable noncovalent thrombin inhibitors that utilize nonbasic groups in the P1 positionT J Tucker, S F Brady, W C Lumma, et al.
Pageof 9

Showing results (71-80 of 81) with videos related to

Sort By:
Pageof 9
Environmental Pollution (Barking, Essex : 1987)|August 7, 2009
Nutrient mitigation capacity in Mississippi Delta, USA drainage ditchesM T Moore, R Kröger, M A Locke, et al.
The Journal of Biological Chemistry|November 7, 1998
Selective inhibition of factor Xa in the prothrombinase complex by the carboxyl-terminal domain of antistasinS S Mao, C T Przysiecki, J A Krueger, et al.
Clinical Chemistry|June 1, 1989
Multicenter evaluation of TDx test for assessing fetal lung maturityJ C Russell, C M Cooper, C H Ketchum, et al.
Physical Review Letters|July 12, 2017
Spatiotemporal Evolution of Runaway Electron Momentum Distributions in TokamaksC Paz-Soldan, C M Cooper, P Aleynikov, et al.
Internal Medicine Journal|December 9, 2014
Consensus guidelines for optimising antifungal drug delivery and monitoring to avoid toxicity and improve outcomes in patients with haematological malignancy, 2014M M Chau, D C M Kong, S J van Hal, et al.
Physical Review Letters|April 24, 2019
Sustained Neutron Production from a Sheared-Flow Stabilized Z PinchY Zhang, U Shumlak, B A Nelson, et al.
Journal of Medicinal Chemistry|November 14, 1997
Synthesis of a series of potent and orally bioavailable thrombin inhibitors that utilize 3,3-disubstituted propionic acid derivatives in the P3 positionT J Tucker, W C Lumma, S D Lewis, et al.
Bioorganic & Medicinal Chemistry Letters|January 5, 1999
C6 modification of the pyridinone core of thrombin inhibitor L-374,087 as a means of enhancing its oral absorptionR C Isaacs, K J Cutrona, C L Newton, et al.
Epilepsy & Behavior : E&B|July 31, 2025
Depressive symptoms in youth with refractory epilepsy: Exploration of seizure, sociodemographic and cognitive factorsS B Brothers, C Wolfe-Christensen, H J Loblein, et al.
Journal of Medicinal Chemistry|August 14, 1998
Design and synthesis of a series of potent and orally bioavailable noncovalent thrombin inhibitors that utilize nonbasic groups in the P1 positionT J Tucker, S F Brady, W C Lumma, et al.
Pageof 9